دورية أكاديمية
[National surveillance of Helicobacter pylori eradication in Denmark. Results based on registration of 34.582 drug prescriptions].
| العنوان: | [National surveillance of Helicobacter pylori eradication in Denmark. Results based on registration of 34.582 drug prescriptions]. |
|---|---|
| عنوان ترانسليتريتد: | National overvågning af Helicobacter pylori-eradikationsterapi i Danmark. Resultater fra registreringen af 34.582 receptudskrivninger. |
| المؤلفون: | Juul KV; Amtssygehuset i Herlev medicinsk afd. C, H:S Hvidovre Hospital., Thomsen OO, Nissen A, Hallas J, Kolmos HJ, Funch-Jensen PM, Lauritsen K |
| المصدر: | Ugeskrift for laeger [Ugeskr Laeger] 1999 Nov 29; Vol. 161 (48), pp. 6635-8. |
| نوع المنشور: | Journal Article |
| اللغة: | Danish |
| بيانات الدورية: | Publisher: Den Alm Danske Laegerforening Country of Publication: Denmark NLM ID: 0141730 Publication Model: Print Cited Medium: Print ISSN: 0041-5782 (Print) Linking ISSN: 00415782 NLM ISO Abbreviation: Ugeskr Laeger Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Copenhagen : Den Alm Danske Laegerforening |
| مواضيع طبية MeSH: | Drug Prescriptions* , Drug Utilization* , Helicobacter pylori*/drug effects, Anti-Bacterial Agents/*administration & dosage , Anti-Ulcer Agents/*administration & dosage , Helicobacter Infections/*drug therapy , Peptic Ulcer/*drug therapy, Adult ; Aged ; Databases, Factual ; Denmark/epidemiology ; Female ; Helicobacter Infections/epidemiology ; Humans ; Incidence ; Male ; Middle Aged ; Peptic Ulcer/epidemiology ; Peptic Ulcer/microbiology ; Registries |
| مستخلص: | We wanted to characterize the use of H. pylori eradication therapy in Denmark (inhabitants 5,227,862). All H. pylori eradication treatments from a nation wide database covering all drug prescriptions in the period January 1994-June 1996 were identified. We found 28,784 out-patients having a prescription with drugs for H. pylori eradication, accounting for 34,582 prescriptions in total. The incidence of new consumers was 220 per 10(5) inhabitants per year, with a maximum at 70-79 years of age. Eighty-six percent of the patients had only one treatment course. Forty-five percent had an anti-ulcer drug prescribed 1-12 months after the H. pylori eradication therapy. Consumption of antibiotics used for H. pylori eradication accounted for 1.4% of the total consumption of antibiotics. In conclusion, the incidence of H. pylori eradication therapy was fairly stable but with changes in the pattern of drug regimens used. Anti-ulcer drugs were often given after H. pylori eradication therapy, suggesting an inappropriate use of eradication treatment. |
| المشرفين على المادة: | 0 (Anti-Bacterial Agents) 0 (Anti-Ulcer Agents) |
| تواريخ الأحداث: | Date Created: 20000122 Date Completed: 20000201 Latest Revision: 20201208 |
| رمز التحديث: | 20231215 |
| PMID: | 10643349 |
| قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!